There’s also been cag repeat lengths correlated with symptoms in a study, and a father and son getting it. But pvdl and notna took it at the same time and got PFS in what they called “lock step”, with identical symptoms.
There’s undoubtedly a predisposition and within that it’s obvious it’s variable as to what’s going to be needed, but I’m as severe as it gets after one 0.25mg dose (had 2 pills six years before). There’s also many instances of people doing strange dosing documented on hair loss forums.
Something I believe our community needs to accept to properly address and consider the problem is how incredibly rare this is. France alone 128000 people took finasteride last year, 30000 of those being prescribed Propecia. m.leparisien.fr/societe/propecia … 379583.php
Many manufacturers manufacture generic versions. Propeciahelp has under 5000 members from across the entire world after a decade.
Merck’s studies are not the only ones on the incidences of adverse events from 5aris. Here is one with a review of nearly 10000 men compared to those who did not take a 5ari, looking at depression and suicidality incidences:
jamanetwork.com/journals/jamain … le/2610105
Here is an analysis of a cohort of 4274 health men prescribed Fin between 2001 and 2013 with a detailed criteria. The total incidence of sexual dysfunction was 6.3%, with 1.1% being persistent pfsfoundation.org/wp-content … m-2015.pdf
The vast use of this drug and tiny cohort of PFS sufferers is a clear pointer to disposition in the genetic level. I believe there’s anecdotal evidence amongst PFS sufferers to conclude going off/on is often a way pfs occurs, but that’s still within our small community of victims who I believe are predisposed. I can’t see how you’re able to conclude otherwise based on any metrics.